A new digital wound care module assists clinicians in selecting appropriate dressings and generating standardized treatment ...

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx® in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid® Facility; ...

The wound healing devices market is largely propelled by the growing incidence of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure sores, along with a rise in surgical ...

Ongoing Enrollment Continues in VALUE Phase III Trial of EscharEx- in Venous Leg Ulcers Commissioning Completed for Expanded NexoBrid- Facility; Full Operational Capacity Expected by Year-End 2025 ...

Researchers confirm that neuropathy and ischaemia are two main factors that result in diabetic foot ulcer with significant impairment of quality of life.

MediWound Ltd (MDWD) reports a 23% revenue increase and strategic advancements, despite facing operational and financial ...

Kure Care, a division of Veracor Group LLC, urges Medicare beneficiaries with chronic wounds to seek regenerative treatment before January 1, 2026 Medicare reimbursement changes. The company offers ...

The latest announcement is out from Mediwound ( (MDWD) ).

Kure Care CEO Kenton Gray urges chronic wound patients to seek treatment immediately. Medicare changes effective January 1, ...

IRVINE, CA / ACCESS Newswire / November 13, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of deep venous ...

Simultaneous kidney and pancreas transplants are a life-saving option for people with Type 1 diabetes. Survival rates after ...

Powys Teaching Health Board has confirmed it has made a series of changes following the death of Edward Funnell, from Llandrindod Wells ...